Integra Lifesciences Shows Market Leadership With Jump To 83 RS Rating

When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. Integra Lifesciences (IART) just met that criteria with a new score of 83.

As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.

This exclusive rating from Investor’s Business Daily identifies price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price performance over the trailing 52 weeks compares to all the other stocks in our database.

Over 100 years of market history shows that the market’s biggest winners typically have an 80 or better RS Rating in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Integra Lifesciences is within a buy range after clearing a 73.45 buy point in a cup with handle. The proper buying range extends to 5% above the initial entry. Once a stock hits that benchmark, it’s best to hold off investing and wait for it to set up another buying opportunity.

In terms of top and bottom line numbers, the company has posted four quarters of accelerating earnings growth. Revenue gains have also risen during the same period.

Integra Lifesciences earns the No. 10 rank among its peers in the Medical-Products industry group. Bio Rad Labs (BIOB) and Staar Surgical (STAA) are also among the group’s highest-rated stocks.


Stocks With Rising Relative Strength Ratings

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button